Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Remodeling MMPIs.

× No keyword cloud information.

11 in total

Review 1. Application of structural dynamic approaches provide novel insights into the enzymatic mechanism of the tumor necrosis factor-alpha-converting enzyme.

Authors: Irit Sagi; Marcos E Milla
Journal: Anal Biochem Date: 2007-09-26 Impact factor: 3.365

2. Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: evidence for developmental, immediate early gene, and lesion response.

Authors: S Rivera; E Tremblay; S Timsit; O Canals; Y Ben-Ari; M Khrestchatisky
Journal: J Neurosci Date: 1997-06-01 Impact factor: 6.167

Review 3. Stromelysin-3 in the biology of the normal and neoplastic mammary gland.

Authors: M C Rio; O Lefebvre; M Santavicca; A Noël; M P Chenard; P Anglard; J A Byrne; A Okada; C H Régnier; R Masson; J P Bellocq; P Basset
Journal: J Mammary Gland Biol Neoplasia Date: 1996-04 Impact factor: 2.673

4. Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.

Authors: Douglas R Hurst; Martin A Schwartz; Yonghao Jin; Mohammad A Ghaffari; Pallavi Kozarekar; Jian Cao; Qing-Xiang Amy Sang
Journal: Biochem J Date: 2005-12-15 Impact factor: 3.857

5. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model.

Authors: J Fang; Y Shing; D Wiederschain; L Yan; C Butterfield; G Jackson; J Harper; G Tamvakopoulos; M A Moses
Journal: Proc Natl Acad Sci U S A Date: 2000-04-11 Impact factor: 11.205

6. Second Generation Triple-Helical Peptide Inhibitors of Matrix Metalloproteinases.

Authors: Manishabrata Bhowmick; Dorota Tokmina-Roszyk; Lillian Onwuha-Ekpete; Kelli Harmon; Trista Robichaud; Rita Fuerst; Roma Stawikowska; Bjorn Steffensen; William Roush; Hector R Wong; Gregg B Fields
Journal: J Med Chem Date: 2017-04-19 Impact factor: 7.446

Review 7. Matrix metalloproteinases: drug targets for myocardial infarction.

Authors: Andriy Yabluchanskiy; Yaojun Li; Robert J Chilton; Merry L Lindsey
Journal: Curr Drug Targets Date: 2013-03 Impact factor: 3.465

Review 8. Matrix metalloproteinase inhibitor development and the remodeling of drug discovery.

Authors: J Thomas Peterson
Journal: Heart Fail Rev Date: 2004-01 Impact factor: 4.214

Review 9. Left ventricular remodeling: one small step for the extracellular matrix will translate to a giant leap for the myocardium.

Authors: Andriy Yabluchanskiy; Robert J Chilton; Merry L Lindsey
Journal: Congest Heart Fail Date: 2013-01-25

10. Structure-based design, synthesis, molecular docking, and biological activities of 2-(3-benzoylphenyl) propanoic acid derivatives as dual mechanism drugs.

Authors: Musa A Ahmed; Faizul Azam; Abir M Rghigh; Abdul Gbaj; Abdulmottaleb E Zetrini
Journal: J Pharm Bioallied Sci Date: 2012-01